Autoimmune encephalitis in psychiatric institutions: current perspectives

References

• van Coevorden-HameeteMHde GraaffETitulaerMJHoogenraadCCSillevis SmittPAEMolecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous systemAutoimmun Rev201413329931224225076
   PubMed Web of Science ®Google Scholar
• ChefdevilleAHonnoratJHampeCSDesestretVNeuronal CNS syndromes likely mediated by autoantibodiesEur J Neurosci20164315321552
   Web of Science ®Google Scholar
• TitulaerMJMccrackenLGabilondoITreatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyLancet Neurol201312215716523290630
   PubMed Web of Science ®Google Scholar
• WeiYCLiuCHLinJJRapid progression and brain atrophy in anti-AMPA receptor encephalitisJ Neuroimmunol20132611–212913323796872
   PubMed Web of Science ®Google Scholar
• IraniSRGelfandJMAl-DiwaniAVincentACell-surface central nervous system autoantibodies: clinical relevance and emerging paradigmsAnn Neurol201476216818424930434
   PubMed Web of Science ®Google Scholar
• LeypoldtFArmangueTDalmauJAutoimmune encephalopathiesAnn N Y Acad Sci201413389411425315420
   PubMed Web of Science ®Google Scholar
• VincentABienCGIraniSRWatersPAutoantibodies associated with diseases of the CNS: new developments and future challengesLancet Neurol201110875977221777830
   PubMed Web of Science ®Google Scholar
• MaatPde GraaffEvan BeverenNMPsychiatric phenomena as initial manifestation of encephalitis by anti-NMDAR antibodiesActa Neuropsychiatr201325312813625287466
   PubMed Web of Science ®Google Scholar
• JoubertBHonnoratJAutoimmune channelopathies in paraneoplastic neurological syndromesBiochim Biophys Acta2015184810 Pt B2665267625883091
   PubMed Web of Science ®Google Scholar
• DalmauJTüzünEWuHYParaneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratomaAnn Neurol2007611253617262855
   PubMed Web of Science ®Google Scholar
• VitalianiRMasonWAncesBZwerdlingTJiangZDalmauJParaneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratomaAnn Neurol200558459460416178029
   PubMed Web of Science ®Google Scholar
• GranerodJAmbroseHEDaviesNWSCauses of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective studyLancet Infect Dis2010101283584420952256
   PubMed Web of Science ®Google Scholar
• IraniSRBeraKWatersPN-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplasticBrain2010133Pt 61655166720511282
   PubMed Web of Science ®Google Scholar
• FloranceNRDavisRLLamCAnti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescentsAnn Neurol2009661111819670433
   PubMed Web of Science ®Google Scholar
• ArmangueTLeypoldtFDalmauJAuto-immune encephalitis as differential diagnosis of infectious encephalitisCurr Opin Neurol201427336136824792345
   PubMed Web of Science ®Google Scholar
• ViaccozADesestretVDucrayFClinical specificities of adult male patients with NMDA receptor antibodies encephalitisNeurology201482755656324443452
   PubMed Web of Science ®Google Scholar
• DalmauJGleichmanAJHughesEGAnti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesLancet Neurol20087121091109818851928
   PubMed Web of Science ®Google Scholar
• PeeryHEDayGSDunnSAnti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiologyAutoimmun Rev2012111286387222440397
   PubMed Web of Science ®Google Scholar
• KayserMSDalmauJAnti-NMDA receptor encephalitis, autoimmunity, and psychosisSchizophr Res20161761364025458857
   PubMed Web of Science ®Google Scholar
• KayserMSDalmauJThe emerging link between autoimmune disorders and neuropsychiatric diseaseJ Neuropsychiatry Clin Neurosci2011231909721304144
   PubMed Web of Science ®Google Scholar
• Rosenthal-SimonsADurrantARHeresco-LevyUAutoimmune-induced glutamatergic receptor dysfunctions: conceptual and psychiatric practice implicationsEur Neuropsychopharmacol201323121659167123791073
   PubMed Web of Science ®Google Scholar
• LejusteFThomasLPicardGNeuroleptic intolerance char-acterizes patients with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis hospitalized in psychiatric institutionsNeurol Neuroimmunol Neuroinflamm201635e28027606355
   PubMed Web of Science ®Google Scholar
• KayserMSTitulaerMJGresa-ArribasNDalmauJFrequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitisJAMA Neurol20137091133113923877059
   PubMed Web of Science ®Google Scholar
• HammerCStepniakBSchneiderANeuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrityMol Psychiatry2014191724362539
   PubMed Web of Science ®Google Scholar
• ZandiMSIraniSRLangBDisease-relevant autoantibodies in first episode schizophreniaJ Neurol2011258468668820972895
   PubMed Web of Science ®Google Scholar
• KayserMSDalmauJAnti-NMDA receptor encephalitis in psychiatryCurr Psychiatry Rev20117318919324729779
   PubMedGoogle Scholar
• CretenCVan Der ZwaanSBlankespoorRJLate onset autism and anti-NMDA-receptor encephalitisLancet20113789821724038
   PubMed Web of Science ®Google Scholar
• LebonSMayor-DuboisCPopeaIAnti-N-methyl-D-aspartate (NMDA) receptor encephalitis mimicking a primary psychiatric disorder in an adolescentJ Child Neurol201227121607161022408145
   PubMed Web of Science ®Google Scholar
• DalmauJLancasterEMartinez-HernandezERosenfeldMRBalice-GordonRClinical experience and laboratory investigations in patients with anti-NMDAR encephalitisLancet Neurol2011101637421163445
   PubMed Web of Science ®Google Scholar
• DesestretVChefdevilleAViaccozACSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitisNeurol Neuroimmunol Neuroinflamm20152618
   Google Scholar
• BusseSBusseMBrixBSeroprevalence of n-methyl-d-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patientsEur Arch Psychiatry Clin Neurosci2014264654555024604707
   PubMed Web of Science ®Google Scholar
• SteinerJWalterMGlanzWIncreased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitisJAMA Psychiatry201370327127823344076
   PubMed Web of Science ®Google Scholar
• PrüssHHöltjeMMaierNIgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairmentNeurology201278221743175322539565
   PubMed Web of Science ®Google Scholar
• ZulianiLGrausFGiomettoBBienCVincentACentral nervous system neuronal surface antibody associated syndromes: review and guidelines for recognitionJ Neurol Neurosurg Psychiatry201283663864522448032
   PubMed Web of Science ®Google Scholar
• LancasterEDalmauJNeuronal autoantigens – pathogenesis, associated disorders and antibody testingNat Rev Neurol20128738039022710628
   PubMed Web of Science ®Google Scholar
• GabilondoISaizAGalánLAnalysis of relapses in anti-NMDAR encephalitisNeurology2011771099699921865579
   PubMed Web of Science ®Google Scholar
• TüzünEZhouLBaehringJMBannykhSRosenfeldMRDalmauJEvidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratomaActa Neuropathol2009118673774319680671
   PubMed Web of Science ®Google Scholar
• GleichmanAJSpruceLADalmauJSeeholzerSHLynchDRAnti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domainJ Neurosci20123232110821109422875940
   PubMed Web of Science ®Google Scholar
• AdellAJiménez-SánchezLLópez-GilXRomónTIs the acute NMDA receptor hypofunction a valid model of schizophrenia?Schizophr Bull201238191421965469
   PubMed Web of Science ®Google Scholar
• PlanagumaJLeypoldtFMannaraFHuman N-methyl D-aspartate receptor antibodies alter memory and behaviour in miceBrain201413819410925392198
   PubMed Web of Science ®Google Scholar
• MikasovaLDe RossiPBouchetDDisrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitisBrain2012135pt 51606162122544902
   PubMed Web of Science ®Google Scholar
• JantzenSUFerreaSWachCIn vitro neuronal network activity in NMDA receptor encephalitisBMC Neurosci2013141723379293
   PubMed Web of Science ®Google Scholar
• LaiMHughesEGPengXAMPA receptor antibodies in limbic encephalitis alter synaptic receptor locationAnn Neurol200965442443419338055
   PubMed Web of Science ®Google Scholar
• JoubertBKerschenPZekeridouAClinical spectrum of encephalitis associated with antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literatureJAMA Neurol201572101163116926280228
   PubMed Web of Science ®Google Scholar
• HöftbergerRvan SonderenALeypoldtFEncephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patientsNeurology201584242403241225979696
   PubMed Web of Science ®Google Scholar
• GrausFBoronatAXifróXThe expanding clinical profile of anti-AMPA receptor encephalitisNeurology2010741085785920211911
   PubMed Web of Science ®Google Scholar
• DalmauJRosenfeldMRParaneoplastic syndromes of the CNSJ Neurol200874327340
   Google Scholar
• BatallerLGalianoRGarcía-EscrigMReversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptorNeurology2010178254256
   Google Scholar
• PengXHughesEGMoscatoEHParsonsTDDalmauJBalice-GordonRJCellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodiesAnn Neurol201577338139825369168
   PubMed Web of Science ®Google Scholar
• GleichmanAJPanzerJABaumannBHDalmauJLynchDRAntigenic and mechanistic characterization of anti-AMPA receptor encephalitisAnn Clin Transl Neurol20141318018924707504
   PubMed Web of Science ®Google Scholar
• GuWBrodtkorbESteinleinOKLGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizuresAnn Neurol200252336436712205652
   PubMed Web of Science ®Google Scholar
• LaiMHuijbersMGLancasterEInvestigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesLancet Neurol20109877678520580615
   PubMed Web of Science ®Google Scholar
• HartIKWatersCVincentAAutoantibodies detected to expressed K+ channels are implicated in neuromyotoniaAnn Neurol19974122382469029073
   PubMed Web of Science ®Google Scholar
• LeeEKMaselliRAEllisWGAgiusMAMorvan’s fibrillary chorea: a paraneoplastic manifestation of thymomaJ Neurol Neurosurg Psychiatry19986568578629854961
   PubMed Web of Science ®Google Scholar
• BarberPAAndersonNEVincentAMorvan’s syndrome associated with voltage-gated K+ channel antibodiesNeurology200054377177210680828
   PubMed Web of Science ®Google Scholar
• BuckleyCOgerJCloverLPotassium channel antibodies in two patients with reversible limbic encephalitisAnn Neurol2001501737811456313
   PubMed Web of Science ®Google Scholar
• WillisMDJonesLVincentAWheelerRO’CallaghanPHamandiKVGKC-complex antibody encephalitisQJM2014107865765924517999
   PubMed Web of Science ®Google Scholar
• IraniSRAlexanderSWatersPAntibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotoniaBrain201013392734274820663977
   PubMed Web of Science ®Google Scholar
• JoubertBSaint-MartinMNorazNCharacterization of a subtype of autoimmune encephalitis with anti–contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizuresJAMA Neurol20167391115112427428927
   PubMed Web of Science ®Google Scholar
• OhkawaTFukataYYamasakiMAutoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptorsJ Neurosci20133346181611817424227725
   PubMed Web of Science ®Google Scholar
• NavarroVKasAApartisEMotor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitisBrain201613941079109326945884
   PubMed Web of Science ®Google Scholar
• MalterMPFrischCSchoene-BakeJCOutcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificityJ Neurol201426191695170524935858
   PubMed Web of Science ®Google Scholar
• MayasiYTakhtaniDGargNLeucine-rich glioma-inactivated protein 1 antibody encephalitis: a case reportNeurol Neuroimmunol Neuroinflamm201414e5125520958
   PubMedGoogle Scholar
• CasaultCAlikhaniKPillayNKochMJerking & confused: leucine-rich glioma inactivated 1 receptor encephalitisJ Neuroimmunol2015289848626616875
   PubMed Web of Science ®Google Scholar
• MesselmaniMFekih-MrissaNZaoualiJMrissaRLimbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodiesAnn Saudi Med2015351767926142944
   PubMed Web of Science ®Google Scholar
• IraniSRMichellAWLangBFaciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitisAnn Neurol201169589290021416487
   PubMed Web of Science ®Google Scholar
• MontojoMTPetit-PedrolMGrausFDalmauJClinical spectrum and diagnostic value of antibodies against the potassium channel-related protein complexNeurologia201562356372
   Google Scholar
• VincentABuckleyCSchottJMPotassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitisBrain2004127370171214960497
   PubMed Web of Science ®Google Scholar
• MerchutMManagement of voltage-gated potassium channel antibody disordersNeurol Clin201028494195920816272
   PubMed Web of Science ®Google Scholar
• RadjaGKCavannaAETreatment of VGKC complex antibody-associated limbic encephalitis: a systematic reviewJ Neuropsychiatry Clin Neurosci201325426427124247853
   PubMed Web of Science ®Google Scholar
• McQuillanRFBargmanJMHyponatraemia caused by LGI1-associated limbic encephalitisNDT Plus20114642442625984214
   PubMedGoogle Scholar
• ThiebenMJLennonVABoeveBFAksamitAJKeeganMVerninoSPotentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibodyNeurology20046271177118215079019
   PubMed Web of Science ®Google Scholar
• IraniSRBuckleyCVincentAImmunotherapy-responsive seizure-like episodes with potassium channel antibodiesNeurology200871201647164818815385
   PubMed Web of Science ®Google Scholar
• TanKMLennonVAKleinCJBoeveBFPittockSJClinical spectrum of voltage-gated potassium channel autoimmunityNeurology200870201883189018474843
   PubMed Web of Science ®Google Scholar
• QuekAMLBrittonJWMcKeonAAutoimmune epilepsy: clinical characteristics and response to immunotherapyArch Neurol201269558259322451162
   PubMedGoogle Scholar
• LancasterEMartinez-HernandezEDalmauJEncephalitis and antibodies to synaptic and neuronal cell surface proteinsNeurology201177217918921747075
   PubMed Web of Science ®Google Scholar
• IraniSRStaggCJSchottJMFaciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotypeBrain2013136pt 103151316224014519
   PubMed Web of Science ®Google Scholar
• SenechalKRThallerCNoebelsJLADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsyHum Mol Genet200514121613162015857855
   PubMed Web of Science ®Google Scholar
• SchulteUThumfartJKlöckerNThe epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1Neuron200649569770616504945
   PubMed Web of Science ®Google Scholar
• LancasterEHuijbersMGMBarVInvestigations of caspr2, an autoantigen of encephalitis and neuromyotoniaAnn Neurol201169230331121387375
   PubMed Web of Science ®Google Scholar
• FukataYAdesnikHIwanagaTBredtDSNicollRAFukataMEpilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmissionScience200631357941792179516990550
   PubMed Web of Science ®Google Scholar
• FukataYLoveroKLIwanagaTDisruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsyProc Natl Acad Sci U S A201010783799380420133599
   PubMed Web of Science ®Google Scholar
• IraniSRPettingillPKleopaKAMorvan syndrome: clinical and serological observations in 29 casesAnn Neurol201272224125522473710
   PubMed Web of Science ®Google Scholar
• LalicTPettingillPVincentACapognaMHuman limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmissionEpilepsia201152112113121054347
   PubMed Web of Science ®Google Scholar
• PoliakSGollanLMartinezRCaspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channelsNeuron19992441037104710624965
   PubMed Web of Science ®Google Scholar
• SunwooJ-SLeeS-TByunJ-IClinical manifestations of patients with CASPR2 antibodiesJ Neuroimmunol2015281172225867463
   PubMed Web of Science ®Google Scholar
• SaizABlancoYSabaterLSpectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this associationBrain2008131pt 102553256318687732
   PubMed Web of Science ®Google Scholar
• AriñoHHöftbergerRGresa-ArribasNParaneoplastic neurological syndromes and glutamic acid decarboxylase antibodiesJAMA Neurol201572887488126099072
   PubMed Web of Science ®Google Scholar
• FoukaPAlexopoulosHAkrivouSTrohatouOPolitisPKDalakasMCGAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disordersJ Neuroimmunol2015281737725867471
   PubMed Web of Science ®Google Scholar
• BuddhalaCHsuCCWuJYA novel mechanism for GABA synthesis and packaging into synaptic vesiclesNeurochem Int2009551–391219428801
   PubMed Web of Science ®Google Scholar
• Gresa-ArribasNAriñoHMartínez-HernándezEAntibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunityPLoS One2015103e012136425774787
   PubMed Web of Science ®Google Scholar
• HonnoratJSaizAGiomettoBCerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patientsArch Neurol200158222523011176960
   PubMedGoogle Scholar
• ÇobanAIsmail KüçükaliCBilgiçBEvaluation of incidence and clinical features of antibody-associated autoimmune encephalitis mimicking dementiaBehav Neurol2014201493537924825964
   PubMed Web of Science ®Google Scholar
• PadmosRCBekrisLKnijffEMA high prevalence of organ-specific autoimmunity in patients with bipolar disorderBiol Psychiatry200456747648215450782
   PubMed Web of Science ®Google Scholar
• MeinckHMFaberLMorgenthalerNAntibodies against glutamic acid decarboxylase: prevalence in neurological diseasesJ Neurol Neurosurg Psychiatry200171110010311413272
   PubMed Web of Science ®Google Scholar
• PittockSJLucchinettiCFParisiJEAmphiphysin autoimmunity: paraneoplastic accompanimentsAnn Neurol20055819610715984030
   PubMed Web of Science ®Google Scholar
• VerninoSLennonVAAutoantibody profiles and neurological correlations of thymomaClin Cancer Res200410217270727515534101
   PubMed Web of Science ®Google Scholar
• MantoMHonnoratJHampeCSDisease-specific monoclonal antibodies targeting glutamate decarboxylase impair GABAergic neurotransmission and affect motor learning and behavioral functionsFront Behav Neurosci201597825870548
   PubMed Web of Science ®Google Scholar
• CarvalhoFMassanoJCoelhoRNeuropsychiatric symptoms in autoimmune encephalopathies: a clinician’s guideInt J Clin Neurosci Ment Heal20141111
   Google Scholar
• AndradeDMTaiPDalmauJWennbergRTonic seizures: a diagnostic clue of anti-LGI1 encephalitis?Neurology201177242140
   Web of Science ®Google Scholar
• Gresa-ArribasNTitulaerMJTorrentsAAntibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective studyLancet Neurol201413216717724360484
   PubMed Web of Science ®Google Scholar
• AmatouryMMerhebVLangerJWangXMDaleRCBrilotFHigh-throughput flow cytometry cell-based assay to detect antibodies to N-methyl-D-aspartate receptor or dopamine-2 receptor in human serumJ Vis Exp201381e5093524300941
   PubMed Web of Science ®Google Scholar
• SinmazNAmatouryMMerhebVRamanathanSDaleRCBrilotFAutoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entryAnn N Y Acad Sci20155117
   Google Scholar
• PollakTAMcCormackRPeakmanMNicholsonTRDavidASPrevalence of anti-N-methyl-d-aspartate (NMDA) antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysisPsychol Med2013461113
   Google Scholar
• MasopustJAndrysCBazantJVysataOKucaKValisMAnti-NMDA receptor antibodies in patients with a first episode of schizophreniaNeuropsychiatr Dis Treat20151161962325834440
   PubMed Web of Science ®Google Scholar
• MasdeuJCGonzález-PintoAMatuteCSerum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophreniaAm J Psychiatry2012169101120112123032395
   PubMed Web of Science ®Google Scholar
• RhoadsJGuirgisHMcKnightCDucheminAMLack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophreniaSchizophr Res20111292–321321421277743
   PubMed Web of Science ®Google Scholar
• PathmanandavelKStarlingJMerhebVAntibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in childrenBiol Psychiatry201577653754725168608
   PubMed Web of Science ®Google Scholar
• LancasterELeypoldtFTitulaerMJIgG antibodies to the NMDA receptor are distinct from IgA and IgM responsesAnn Neurol20141822832
   Google Scholar
• LennoxBRColesAJVincentAAntibody-mediated encephalitis: a treatable cause of schizophreniaBr J Psychiatry20122002929422297586
   PubMed Web of Science ®Google Scholar
• BarryHHardimanOHealyDGAnti-NMDA receptor encephalitis: an important differential diagnosis in psychosisBr J Psychiatry2011199650850921984802
   PubMed Web of Science ®Google Scholar
• KuppuswamyPSTakalaCRSolaCLManagement of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directionsGen Hosp Psychiatry201436438839124731834
   PubMed Web of Science ®Google Scholar
• ChapmanMRVauseHEAnti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatmentAm J Psychiatry2011168324525121368306
   PubMed Web of Science ®Google Scholar
• SchmittSEPargeonKFrechetteESHirschLJDalmauJFriedmanDExtreme delta brush; a unique EEG pattern in adults with anti-NMDA receptor encephalitisNeurology201279111094110022933737
   PubMed Web of Science ®Google Scholar
• Petit-PedrolMArmangueTPengXEncephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodiesLancet Neurol201413327628624462240
   PubMed Web of Science ®Google Scholar
• OhkawaTSatakeSYokoiNIdentification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitisJ Neurosci201434248151816324920620
   PubMed Web of Science ®Google Scholar
• PettingillPKramerHBCoeberghJAAntibodies to GABAA receptor alpha1 and gamma2 subunits: Clinical and serologic characterizationNeurology201584121233124125636713
   PubMed Web of Science ®Google Scholar
• LancasterELaiMPengXAntibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigenLancet Neurol201091677619962348
   PubMed Web of Science ®Google Scholar
• BoronatASabaterLSaizADalmauJGrausFGABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disordersNeurology201176979580021357831
   PubMed Web of Science ®Google Scholar
• HöftbergerRTitulaerMJSabaterLEncephalitis and GABAB receptor antibodies: Novel findings in a new case series of 20 patientsNeurology201381171500150624068784
   PubMed Web of Science ®Google Scholar
• LancasterEMartinez-HernandezETitulaerMJAntibodies to metabotropic glutamate receptor 5 in the Ophelia syndromeNeurology201177181698170122013185
   PubMed Web of Science ®Google Scholar
• MatAAdlerHMerwickAOphelia syndrome with metabotrophic glutamat receptor 5 antibodies in CSFNeurology20132C13491350
   Web of Science ®Google Scholar
• PrüssHRothkirchMKoppULimbic encephalitis with mGlur5 antibodies and immunotherapy-responsive prosopagnosiaNeurology201483151384138625194012
   PubMed Web of Science ®Google Scholar
• DaleRCMerhebVPillaiSAntibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disordersBrain2012135113453346823065479
   PubMed Web of Science ®Google Scholar
• HutchinsonMWatersPMcHughJProgressive encephalomyelitis, rigidity and myoclonus: a novel glycine receptor antibodyNeurology200812891292
   Web of Science ®Google Scholar
• PiotrowiczAThümenALeiteMIVincentAMoserAA case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): Clinical course, treatment and CSF findingsJ Neurol2011258122268227021541785
   PubMed Web of Science ®Google Scholar
• McKeonAMartinez-HernandezELancasterEGlycine Receptor Autoimmune Spectrum With Stiff-Man Syndrome PhenotypeJAMA Neurol20137014423090334
   PubMed Web of Science ®Google Scholar
• Carvajal-GonzálezALeiteMIWatersPGlycine receptor antibodies in PERM and related syndromes: Characteristics, clinical features and outcomesBrain201413782178219224951641
   PubMed Web of Science ®Google Scholar
• VincentAIraniSRCaspr2 antibodies in patients with thymomasJ Thorac Oncol2010510 Suppl 4S277S28020859119
   PubMed Web of Science ®Google Scholar
• BoronatAGelfandJMGresa-ArribasNEncephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channelsAnn Neurol201373112012823225603
   PubMed Web of Science ®Google Scholar
• TobinWOLennonVAKomorowskiLDPPX potassium channel antibody: Frequency, clinical accompaniments, and outcomes in 20 patientsNeurology201483201797180325320100
   PubMed Web of Science ®Google Scholar
• MalterMPHelmstaedterCUrbachHVincentABienCGAntibodies to glutamic acid decarboxylase define a form of limbic encephalitisAnn Neurol201067447047820437582
   PubMed Web of Science ®Google Scholar
• AliFRowleyMJayakrishnanBTeuberSGershwinMEMackayIRStiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: Protean additions to the autoimmune central neuropathiesJ Autoimmun2011372798721680149
   PubMed Web of Science ®Google Scholar